中性粒细胞作为胰腺癌肝转移的有希望的治疗靶点。
Neutrophils as promising therapeutic targets in pancreatic cancer liver metastasis.
发表日期:2024 Aug 11
作者:
Minjie Guo, Wanying Sheng, Xiao Yuan, Xu Wang
来源:
INTERNATIONAL IMMUNOPHARMACOLOGY
摘要:
胰腺癌的特点是预后极差,并且面临着巨大的治疗挑战。肝转移是胰腺癌患者死亡的主要原因。最近的研究强调了中性粒细胞对肿瘤发生和进展的显着影响,以及它们在胰腺癌肿瘤微环境中的关键作用。中性粒细胞浸润在胰腺癌的进展和预后中起着至关重要的作用。中性粒细胞通过多种机制促进胰腺癌肝转移,包括血管生成、免疫抑制、免疫逃避和上皮间质转化(EMT)。因此,靶向中性粒细胞有望成为抑制胰腺癌肝转移的重要治疗策略。本文总结了中性粒细胞参与胰腺癌肝转移的研究结果,并分析了它们作为治疗靶点的潜力。这项研究可能为胰腺癌的治疗提供新的见解,改善该疾病患者的预后。版权所有 © 2024 Elsevier B.V. 保留所有权利。
Pancreatic cancer is characterized by an extremely poor prognosis and presents significant treatment challenges. Liver metastasis is the leading cause of death in patients with pancreatic cancer. Recent studies have highlighted the significant impact of neutrophils on tumor occurrence and progression, as well as their crucial role in the pancreatic cancer tumor microenvironment. Neutrophil infiltration plays a critical role in the progression and prognosis of pancreatic cancer. Neutrophils contribute to pancreatic cancer liver metastasis through various mechanisms, including angiogenesis, immune suppression, immune evasion, and epithelial-mesenchymal transition (EMT). Therefore, targeting neutrophils holds promise as an important therapeutic strategy for inhibiting pancreatic cancer liver metastasis. This article provides a summary of research findings on the involvement of neutrophils in pancreatic cancer liver metastasis and analyzes their potential as therapeutic targets. This research may provide new insights for the treatment of pancreatic cancer and improve the prognosis of patients with this disease.Copyright © 2024 Elsevier B.V. All rights reserved.